A Nursing Intervention Program to Improve Therapeutic Adherence in Elderly People With Acute Myocardial Infarction
A Nursing Intervention Program Significantly Improves Therapeutic Adherence in Elderly People With Acute Myocardial Infarction: a Randomized Controlled Study
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with STEMI aged 75 years or older underwent primary percutaneous coronary intervention (PCI)
Exclusion Criteria:
- Patients who refused to participate in the study
- Patients unable to perform geriatric assessment.
- Patients admitted to nursing homes or social health centres.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: nursing intervention group
An educational interview by trained nurses was performed at three months in patients allocated to the intervention group.
The visit was carried out at the hospital.
Family and caregivers were also asked to attend this visit for instruction.
For patients unable to move, the nursing team went to their home to perform the intervention, or it was conducted by phone.
The duration of this interview was approximately 40 minutes and was focused on some measures and recommendations to improve or maintain adherence.
Then, there is a reminder call at 6 months.
|
educational information
|
|
No Intervention: Usual care group
The patient is followed up and regular visits
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of patients with therapeutic adherence
Time Frame: 12 months after admission
|
The main outcome measured was therapeutic adherence 12 months after admission. The definition of adherence was a single measure taking into account 4 different methods (see below). Patients were considered adherent when the 4 criteria were present (called "global adherence").Measurement unit was: Number of patients with therapeutic adherence
|
12 months after admission
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of readmission,
Time Frame: During the 12 months after the admission
|
Need for hospital readmission
|
During the 12 months after the admission
|
|
Rate of visits to the emergency room
Time Frame: During the 12 months after the admission
|
Need for emergency visits at hospital
|
During the 12 months after the admission
|
|
Rate of mortality
Time Frame: During the 12 months after the admission
|
Deaths of cardiac origin were those caused by myocardial infarction, sudden death or heart failure.
|
During the 12 months after the admission
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Elena Calvo, RN, Nurse
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- PR034/16
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.